We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Made for walking

6 Dec 2021 By Robert Cyran

The $40 bln drugstore operator may sell its UK chain, less than a decade after buying it. A sale could raise $8 bln for the U.S. group to beef up its own in-store clinics. And if Chairman Stefano Pessina wants one last big deal, a leaner Walgreens would be an easier target.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)